baber/WOPTO huggingface dataset:
Patent AP-655-A (AP)
Title: Use of betaine and adjuvant to improve the yield of plants.
Inventor: PEHU EIJA
IPC: C05C11/00
Filed: 1995-09-07
Granted: 1998-07-30
Abstract: The invention relates to the exogenous synergistic use of betaine and adjuvant to improve the yeild of plants. According to the invention, betaine adjuvant can be applied either together or separately and used under noth normal and stress conditions. The invention also relates to a synergistic combination containing betaine and adjuvant, to plants treated exogenously with synergistic amounts of betaine and adjuvant and to products obtained from such plants.
Patent AU-1287801-A (AU)
Title: Method and installation for continuous bactericidal treatment of edible meat portions
Inventor: CHERICI ERNEST
IPC: A23B4/02
Filed: 2000-11-03
Abstract: The invention concerns a method which consists in generating by spraying in the treatment chamber (8) a mist of treating solution, and in causing said mist to pass through the portions to be treated (2). The invention is useful for bactericidal treatment of bird carcasses (2) with a trisodium phosphate solution.
Patent AU-1714801-A (AU)
Title: Substituted isoxazolines and their use as antibacterial agents
Inventor: BETTS MICHAEL JOHN
IPC: A61K31/4439
Filed: 2000-11-28
Abstract: Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, wherein, for example, X is O, S or NH; HET is an optionally substituted C-linked 5-membered heteroaryl ring containing 2 to 4 heteroatoms independently selected from N, O and S; Q is selected from, for example, Q1 and Q2: R<SUP>2 </SUP>and R<SUP>3 </SUP>are independently hydrogen or fluoro; T is selected from a range of groups, for example, an N-linked (fully unsaturated) 5-membered heteroaryl ring system or a group of formula (TC5): wherein Rc is, for example, R<SUP>13</SUP>CO-, R<SUP>13</SUP>SO<SUB>2</SUB>- or R<SUP>13</SUP>CS-; wherein R<SUP>13 </SUP>is, for example, optionally substituted ( 1 - 10 C)alkyl or R<SUP>14</SUP>C(O)O( 1 - 6 C)alkyl wherein R<SUP>14 </SUP>is optionally substituted ( 1 - 10 C)alkyl; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
Patent AU-1735492-A (AU)
Title: Novel peptides and pseudopeptides derived from tachykinin, process for their preparation and the pharmaceutical compositions containing these
IPC: C07K5/097
Filed: 1992-06-03
Abstract: Peptide derivs. of formula (I) A-B-N(R1)(R2), their enantiomers, diastereomers, epimers, and addn. salt with acids or bases, are new. In (I), R1 and R2 are H, 1-6C alkyl, 3-7C cycloalkyl or benzyl; B is aromatic amino acid (AA) residue; A is P-A6-A5-A4-; A4 is residue of 2-azabicyclo(2.2.2)octane-3-carboxylic acid (Abo) or 2-naphthylamine (Nal); A5 is bond, Phe, Nal, or Abo; A6 is bond, Trp (opt. protected by CHO or Me) or Abo; P is H, benzyloxycarbonyl (Z), tert.-butoxycarbonyl (Boc), 3-indolylcarbonyl, benzhydrylcarbonyl or 9-fluorenylmethyoxycarbonyl (Fmoc); a peptide bond between A5 and A6 may be replaced by CH2NH or CH2S; all AA are optically pure with D or L configuration.
Patent AU-1762099-A (AU)
Title: Method of producing xylose
Inventor: HEIKKILA HEIKKI
IPC: C13B20/14
Filed: 1998-12-22
Abstract: The present invention relates to a method of producing xylose by chromatographic separation of the xylose from a sulphite cooking liquor containing for example xylose and xylonic acid. The xylose yield of the separation is affected by the xylonic acid and xylose content in the cooking liquor used in the separation and the amount of base cation used in the sulphite cooking.
Patent AU-1823592-A (AU)
Title: Transluminal implantation device
IPC: A61F2/966
Filed: 1992-06-12
Abstract: A device (1) for transluminal implantation of a substantially tubular, radially expansible stent (33), comprising a central tube (7) or rod surrounded by an outer tube (9) axially displaceable relative said central tube (7) or rod, the radial dimensions of said tubes or tube and rod being such as to form an annular space therebetween capable of accommodating said stent (33) in an unexpanded state, and means for axial displacement of said outer tube (9) relative to said central tube (7) or rod. In said device the central tube (7) or rod, at a distal end thereof, is provided with a section of reduced diameter at the proximal end of which there is an undercut groove forming a circumferential flange (21) within which a proximal end of said stent (33) rests until release of the stent (33) by rearward displacement of said outer tube (9). <IMAGE>
Patent AU-1937392-A (AU)
Title: Pharmacologically active hydrazine derivatives and processes for the preparation thereof
IPC: C07C271/12
Filed: 1992-07-01
Abstract: The invention relates to compounds of the formula <IMAGE> in which R1 and R9 are, independently of one another, hydrogen, acyl, unsubstituted or substituted alkyl, alkenyl or alkynyl; heterocyclyl; sulpho, or sulphonyl which is substituted by unsubstituted or substituted alkyl, aryl, heterocyclyl, alkoxy, which is unsubstituted or substituted, or by aryloxy; sulphamoyl which is unsubstituted or substituted on the nitrogen; or phosphoryl which is substituted by one or two radicals selected independently of one another from unsubstituted or substituted alkyl, from unsubstituted or substituted cycloalkyl, from aryl, from hydroxyl, from unsubstituted or substituted alkoxy, from cycloalkoxy and from aryloxy, with the proviso that not more than one of the radicals R1 and R9 is hydrogen; and R2 and R8 are each, independently of one another, hydrogen or one of the radicals mentioned above for R1 and R9; or the pairs of substituents R1 and R2 or R8 and R9 can each, independently of one another, form together with the nitrogen atom to which they are bonded certain heterocyclic rings; R3 and R4 are, independently of one another, hydrogen, unsubstituted or substituted alkyl or cycloalkyl; aryl; heterocyclyl; or unsubstituted or substituted alkenyl; or R3 and R4 together are unsubstituted or substituted alkylene, alkylidene or benzo-fused alkylene; R5 is hydroxyl; R6 is hydrogen; or R5 and R6 together are oxo; and R7 is unsubstituted or substituted alkyl or cycloalkyl; aryl; heterocyclyl; or unsubstituted or substituted alkenyl; as well as the salts of the said compounds where salt-forming groups are present, furthermore process for the preparation thereof, pharmaceutical products, the use as pharmaceutical composition or for the preparation of pharmaceutical products, as well as intermediates for the preparation of these compounds.
Patent AU-2085588-A (AU)
Title: Ion conductors
Inventor: GILES JEREMY ROGER MARTIN
IPC: H01M6/18
Filed: 1988-07-14
Abstract: PCT No. PCT/GB88/00565 Sec. 371 Date Feb. 5, 1990 Sec. 102(e) Date Feb. 5, 1990 PCT Filed Jul. 14, 1988 PCT Pub. No. WO89/00771 PCT Pub. Date Jan. 26, 1989.An ion conducting polymeric material characterized in that it comprises a mixture of at least three components (a), (b), and (c): (a) one or more structural materials, (b) one or more low mass plasticizers, and (c) one or more amorphous ion-solvating polymers and optionally containing (d) one or more ionic salts. Preferably the structural material is poly(ethylene oxide) and the ion-solvating polymer is an oxymethylene linked polyethylene glycol having a repeat sequence [(CH2CH2O)aCH2O] where a has an average value of 4 to 15.
Patent AU-2094995-A (AU)
Title: Microencapsulated compositon of chlorpyrifos or endosulfan
Inventor: MARCUS ARIE
IPC: A01N57/16
Filed: 1995-03-03
Abstract: The present invention relates to a microencapsulated chlorpyrifos or endosulfan composition comprising a polyurea shell and one or more photostable ultraviolet and visible light absorbent compound having a log molar extinction coefficient of from about 2 to 5 with respect to radiation having wave lengths in the range of about 310 to 450 nanometers, wherein said photostable ultraviolet and visible light absorbent compound does not react with the monomer used in building the polyurea shell. The result is a microencapsulated composition having unexpected long, extended insecticidal activity with high toxicity to target species and very low toxicity to non-target animals.
Patent AU-2095388-A (AU)
Title: Method for the direct determination of physical properties of hydrocarbon products
Inventor: ESPINOSA ALAIN
IPC: G01N33/22
Filed: 1988-08-16
Abstract: The properties of a product and/or the yield of the product from a hydrocarbon conversion or separation process are determined from the NIR (Near Infra Red) spectrum of the feedstock by a method which comprises the following steps:   (a) determining with an IR spectrometer the absorbance of the feedstock at a certain number of frequencies in the spectral range 16667 to 3840 cm<-><1>, preferably 12500 to 3840 cm<-><1>, most preferably 4760 to 4999 cm<-><1> starting from a defined base line, and (b) determining the property by applying a correlation between the property and the absorbance values, the correlation being determined experimentally by multivariate regression, depending on the type of spectrometer used, the property required, and the frequencies used.
Patent AU-2109495-A (AU)
Title: N-p-Halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-((3,4-(methylene-dioxy)phenoxy)methyl) piperidine
Inventor: FOGUET RAFAEL
IPC: A61P25/24
Filed: 1995-03-17
Abstract: PCT No. PCT/EP95/01007 Sec. 371 Date Feb. 20, 1996 Sec. 102(e) Date Feb. 20, 1996 PCT Filed Mar. 17, 1995 PCT Pub. No. WO95/25732 PCT Pub. Date Sep. 28, 1995The invention relates to new N-benzoylmethyl-piperidines of the general formula (I):    <IMAGE>  (I)  wherein X is a halogen atom, as well as their pharmaceutically acceptable addition salts. The compounds are potentially useful to treat depressions.
Patent AU-2198588-A (AU)
Title: Hermetically sealed package and method of producing the same
Inventor: ODAKA HIROSHI
IPC: B65D77/20
Filed: 1988-09-07
Abstract: A hermetically sealed package comprising:   (a) a multilayer container 10 comprising at least an innermost layer a and a layer b adjacent to the innermost layer a, the innermost layer a and the layer b adjacent to the innermost layer a being joined by a pressure sensitive adhesive c, the multilayer container 10 including     (1) a recessed portion 11; (2) a flat flange portion 12 adjoining integrally the rim of the recessed portion 11; and (3) a notch 13 surrounding the boundary between the recessed portion 11 and the flat flange portion 12; the notch 13 being provided on the flat flange portion 12 in the innermost layer a of the multilayer container 10; and     (b) a top film 20 including   (1) a lid portion 21 for sealing the multilayer container 10, the lid portion 21 being adhered strongly to the flat flange portion 12 of the multilayer container 10 at the outside of the notch 13; and (2) a tab portion 22 for picking the top film 20, the tab portion 22 extending from the rim of the lid portion 21, being integral with the lid portion 21, and being not adhered to the flat flange portion 12;   the coefficient of adhesion between the multilayer container 10 and the top film 20 being larger than the coefficient of adhesion between the innermost layer a of the multilayer container 10 and the layer b adjacent to the innermost layer a of the multilayer container 10 generated by the pressure sensitive adhesive c, whereby upon progressive separation of the top film 20 from the tab portion 22, the innermost layer a is progressively peeled from the layer b adjacent to the innermost layer a, with the innermost layer a inside the notch 13 remaining unpeeled; and the pressure sensitive adhesive c enabling to reseal the hermetically sealed package after opening.
Patent AU-2355792-A (AU)
Title: A tramadol n-oxide material, enantiomers and compositions thereof, and their use
IPC: A61P1/12
Filed: 1992-09-11
Abstract: This invention relates to a tramadol N-oxide material, enantiomers and compositions thereof and their use. The tramadol N-oxide material and compositions thereof are pharmacologically useful in treating pain, diarrhea and tussive conditions. The tramadol N-oxide is also subject to less side-effects as compared to pure opiate based compositions, such as abuse liability, tolerance, constipation and respiratory depression. Furthermore, the tramadol N-oxide material when administered orally exhibits analgesia for a longer duration than an equi-analgesic amount of tramadol.
Patent AU-2407695-A (AU)
Title: Device for cleaning a surface
Inventor: ALTVATER AXEL
IPC: A61C8/00
Filed: 1995-04-25
Abstract: PCT No. PCT/EP95/01551 Sec. 371 Date Oct. 25, 1996 Sec. 102(e) Date Oct. 25, 1996 PCT Filed Apr. 25, 1995 PCT Pub. No. WO95/28893 PCT Pub. Date Nov. 2, 1995A device is proposed for cleaning the surface of inserted oral implants and/or the abutments placed thereon. The device is distinguished by the provision of a cleaning curette (31, 131) which at least partially covers the surface to be cleaned.
Patent AU-2557692-A (AU)
Title: Screened electromagnetic coil of restricted length having optimized field and method
IPC: G01R33/421
Filed: 1992-08-24
Abstract: A primary gradient coil and a screen coil for use with the primary coil are constructed to create a substantially null field adjacent to the screen coil and a substantially distortion free linear gradient field adjacent to the gradient coil. A method is disclosed for generating the coils by considering the screen coil to be of infinite length, deriving a Fourier transform of the axial and other components of the field in which the transform is the sum of the permissible harmonic modes on the coil surface in which a coefficient Cn is derived representing the nth harmonic. A perfect screen coil is created and the number of terms Cn selected using least squares optimization until there is no longer a significant change in the resulting field. Examples are given for creating unscreened, screened, linear, axial and transverse gradient field coils.
Patent AU-2687795-A (AU)
Title: A device for separating extremely fine particles from air
Inventor: GLEHN ANDREAS VON
IPC: B03C3/30
Filed: 1995-06-06
Abstract: PCT No. PCT/SE95/00653 Sec. 371 Date Dec. 6, 1996 Sec. 102(e) Date Dec. 6, 1996 PCT Filed Jun. 6, 1995 PCT Pub. No. WO95/33569 PCT Pub. Date Dec. 14, 1995A particle separating arrangement includes a filter tube (1) that is made of electrostatically chargeable fibres, for instance electrete fibres, and through which an axial air stream can pass radially in a direction from within outwardly. Within the tube (1) an insert (2) is placed, including a carrier (3) which extends transversely to the tube, the carrier having a plurality of strip elements (4) arranged to be set in motion by the passing air stream and thereby be rubbed against each other in order to produce an electrostatically charged field in their environs. This field is used to automatically and continuously keep the chargeable fibres in the filter tube wall (1) electrostatically charged.
Patent AU-2758088-A (AU)
Title: Substituted 6-phenyldihydro-3(2h)-pyridazinones, a process for their preparation and pharmaceutical preparations containing these compounds
Inventor: HERTER ROLF DR
IPC: C07D401/10
Filed: 1988-12-23
Abstract: 6-Substd. phenyl-pyridazin-3-one derivs. of formula (I) and their salts are new: A=(i)-(iv), R1 = NO2, NH2, OH, CN or halo; R2 = H, Me or CH2OH; R3 = H, 1-6C alkyl (opt. substd. by an OH or NH2 gp.); opt. substd. aryl or heteroaryl; CN; acyl; opt. substd. aroyl; COOH or 1-6C alkoxycarbonyl; m = 1-3; n = 2-4.
Patent AU-2934995-A (AU)
Title: Car for lifting and/or moving containers
Inventor: BREZOVITS LASZLO
IPC: B65G63/02
Filed: 1995-07-12
Abstract: Car for lifting and/or moving containers, comprising: a base structure (2) provided with wheels (1); parallel beams (3) arranged on the base structure (2); container supports (4) above the beams (3); carriages (6) rolling on the beams (3) and being provided with means for lifting and/or moving containers (16), said means being foldable below the level of the container supports (4) wherein said container supports (4) are arranged outside of the path of the carriages (6).
Patent AU-3053492-A (AU)
Title: Plaster and/or paint product
IPC: C04B28/06
Filed: 1992-11-18
Abstract: The present invention relates to a product (1) so arranged as to reduce the occurrence of so-called lime precipitation in connection with the application of rendering, surface colour finish or a combined product thereof, containing a hydraulic binding agent, to a facade (2) or some other similar surface, and as to permit the appropriately slow binding of the substances present in the product (1) in order to permit its manageable application along the intended application surface. The following are included in same according to the invention: a rapid-binding binding agent in the form of aluminous cement, preferably Lafarge <R> SEC 71, at a level of 5-30 percent by weight and filler at a level of 60-95 percent by weight. The binding process of the product is slow, in spite of the normally rapid-binding characteristics of the binding agent. The absent or low lime-precipitation characteristic of the binding agent is also utilized.
Patent AU-3130800-A (AU)
Title: Apparatus for collecting and removing solid particles from a flowing fluid
Inventor: HUBER HANS GEORG
IPC: E03F5/14
Filed: 2000-05-03
Abstract: The method for intermittently applying particulate material (8) to a substrate involves providing a continuous supply of particulate material from a supply source to a valve having a powder application phase and a recycle phase. The valve is dispose the powder application phase to allow particulate material to pass through it and to fall freely onto at least a portion of the substrate. The valve is disposed in the recycle phase to prevent dispensing of the particulate material onto the substrate and t retain the particulate material within the valve to be conveyed back to the supply source.
Patent AU-3264099-A (AU)
Title: Identification of objects by a reader
Inventor: HODSON TREVOR MEREDITH
IPC: G01S13/74
Filed: 1999-03-03
Abstract: An identification system is provided for identifying a plurality of object-based transponders (14, 16, 18, 20) using an interrogator (10). The interrogator (10) includes a transmitter for transmitting an interrogation signal to the transponders, a receiver for receiving identification signals from the transponders, and processor means (21) for determining the individual and correct receipt of an identification signal. The transponders operate on the basis of backscatter modulation, and include a detector for detecting the presence of an interrupt signal from the interrogator. Control logic responsive to the detector is arranged to cease signal transmission from the transponder if the transponder completes transmission of the identification signal without receiving an interrupt signal during such transmission. The interrogator (10) is arranged to receive the identification signals from the transponders (14, 16, 18, 20) and substantially contemporaneously to determine if any identification signal has been individually and correctly received. In the event of any identification signal is being individually and correctly received, the interrogator (10), at substantially the same time, transmits a common interrupt signal for temporarily suspending signal transmission from a transponder (14) if the transponder is transmitting its identification signal at the time it receives the interrupt signal. The transponder (14) independently ceases signal transmission if it completes transmission of an identification signal without receiving an interrupt signal.
Patent AU-3365097-A (AU)
Title: Container for packaging and unwinding a coil of welding wire
Inventor: B-JENSEN BERNT-INGE
IPC: B65H49/08
Filed: 1997-05-20
Abstract: The invention concerns a container (1) for packaging and unwinding a coil of welding wire, which comprises a box-like body (4) having inner walls (5b) forming a polygonal periphery for accomodating a circular coil (2) of wire (3) during the transportation and the unwinding of the coil (2). The container also comprises a cover (6) at the upper end of the body (4), a bottom (26) at the lower end of the body, a retainer device (17) arranged inside the body on the coil for preventing accidental entanglement of the wire turns during the unwinding of the wire from the coil, and a wire conduit device (10) for the guidance of the wire out from the body during the unwinding. At least in some places the retainer device (17) is in contact with the inner walls of the body, especially during the unwinding. The cover (6) is flat and is placed at the top of the body both during the transportation and the unwinding of the wire (3). The wire conduit device (10) is attached to the cover during the unwinding.
Patent AU-3580795-A (AU)
Title: Dental cavity conditioning
Inventor: LINDSKOG SVEN
IPC: A61K6/40
Filed: 1995-09-14
Abstract: A process for the conditioning of dental cavities by etching in preparation for bonding restoration to enamel and dentin, comprising the steps: a) etching the dentin part of a dental cavity using an aqueous composition containing, as an active constituent, EDTA, in an effective amount, and b) etching the enamel part of said cavity using a conventional etching acid; and a kit for use in such process for conditioning.
Patent AU-3633989-A (AU)
Title: Barium and/or strontium titanate crystal manufacture
Inventor: LEROT LUC
IPC: C01G23/00
Filed: 1989-06-13
Abstract: An amorphous powder of titanium oxide and of barium and/or strontium oxide is precipitated by the hydrolysis of titanium alcoholate in the presence of barium oxide, hydroxide or alcoholate or strontium oxide, hydroxide or alcoholate and an acid organic compound containing more than 6 carbon atoms, and the amorphous powder is heated while being treated with a stream of gas containing water vapour, ammonia or CO2, to crystallize the barium or strontium titanate and distill off the acid organic compound. The barium or strontium titanate crystals are less than one micron in size and have an irregular, angular morphology.
Patent AU-3719695-A (AU)
Title: Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies
Inventor: HANSEN HANS J
IPC: A61K47/48
Filed: 1995-09-28
Abstract: A humanized monoclonal antibody, comprising the complementarity-determining regions of a parental murine Class III, anti-CEA monoclonal antibody engrafted to the framework regions of a heterologous antibody, wherein the humanized monoclonal antibody retains the binding specificity of, but is less immunogenic in a heterologous host than, the parental murine monoclonal antibody. A preferred murine Class III, anti-CEA monoclonal antibody is the MN-14 antibody and the preferred heterologous antibody is from a human. Also provided are DNA constructs and vectors for producing the humanized monoclonal antibodies, and diagnostic and therapeutic conjugates using same.
Patent AU-3819897-A (AU)
Title: Method of triggering oxygen scavenging composition with pulsed light
Inventor: COOK PHILIP H JR
IPC: B65B55/08
Filed: 1997-07-30
Abstract: A method for triggering an oxygen scavenging composition for use in packaging an oxygen sensitive article includes the steps of providing an oxygen scavenging composition comprising an oxidizable organic compound and, optionally, a transition metal catalyst, and exposing the composition to a source of pulsed light wherein each pulse has a duration of between 1 microsecond and 1 millisecond, a frequency of between 0.1 to 100 Hertz, and a total intensity of at least 350 mW/cm<SUP>2 </SUP>so that each pulse provides the composition with a dose of UV light of at least 0.1 J/cm<SUP>2 </SUP>so as to provide a triggered composition. The triggered composition can be applied to an article so as to provide an oxygen scavenging package. An apparatus and packaging system are also disclosed.